Lib Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lib Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lib Therapeutics Today - Breaking & Trending Today

Lerodalcibep Shows Promise for HeFH in Phase 3 LIBerate-HeFH Trial

Published: August 30, 2023

Data from the first of 3 phase 3 trials examing lerodalcibep provide insight into the effects of the once-monthly PCSK9 inhibitor in patients with heterozygous familial hypercholesterolemia.

Source: hcplive.com

Related Topics:

Hcplive Derick RaalDerick RaalEvan SteinEuropean Society Of CardiologyCarbohydrate Lipid Metabolism Research UnitFaculty Of Health SciencesUniversity Of WitwatersrandEuropean SocietyLipid Metabolism Research UnitHealth SciencesStandard DeviationStandard ErrorLib TherapeuticsPcsk9 InhibitorLdl C